loader2
Partner With Us NRI

Dec 08, 2021

Category

Others

AUM (Cr.)

56.45

Exit Load (%)

0.00

Min Inv Lumpsum

1,000

Expense Ratio

0.21

Sharpe Ratio

-21.09

Beta Ratio

0.00

Fund Manager

Mehul Dama

Inception Date

Jul 06, 2021

Risk Level

Very High

Investment Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

Nifty Pharma TRI

Return Calculator

Investment Type

SIP Lumpsum

Company

Period(Year)

Amount

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Nifty Pharma ETF -2.98 0 0 0 0 -6.48
Benchmark - Nifty Pharma TRI -5.09 -5.53 6.13 15.91 4.78 0
Category Average - BEST ETFS/INDEX -2.24 8.64 25.03 15.38 13.65 16.83
Category Rank 5/2 2/2 3/2 3/2 1/2 2/2
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Nippon India ETF PSU Bank BeES 29.6781 2.38 45.92 -1.75 -3.27 387.55 0.49 5,000.00 invest
ICICI Pru IT ETF 366.4215 1.95 61.06 0.00 0.00 2,436.50 0.20 5,000.00 invest
Aditya Birla SL Nifty IT ETF 35.8990 1.95 0.00 0.00 0.00 33.93 0.00 500.00 invest
SBI ETF IT 366.9304 1.95 61.43 0.00 0.00 855.45 0.22 5,000.00 invest
Nippon India ETF Liquid BeES 1,000.0000 -57.00 3.23 1.09 0.66 4,053.01 0.65 2,500,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)		 4 Months Trends
Equity-Sun Pharma.Inds. Nov 30, 2021 10.93 18.10 3.04
Equity-Divi`s Lab. Nov 30, 2021 8.35 13.82 2.93
Equity-Dr Reddy`s Labs Nov 30, 2021 7.64 12.65 9.15
Equity-Cipla Nov 30, 2021 6.63 10.97 16.64
Equity-Lupin Nov 30, 2021 2.86 4.73 4.16
Equity-Laurus Labs Nov 30, 2021 2.68 4.43 7.23
Equity-Aurobindo Pharma Nov 30, 2021 2.50 4.14 4.19
Equity-Gland Pharma Nov 30, 2021 2.37 3.91 5.14
Equity-Alkem Lab Nov 30, 2021 2.26 3.74 8.43
Equity-Biocon Nov 30, 2021 2.21 3.65 11.55

latest news

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 13 December 2021 as the record date ...

Dec 08, 2021 11:49

Nippon India Mutual Fund Announces Appointment of Key Personnel

Nippon India Mutual Fund has announced that Parag Rajendrakumar Khetan has ...

Nov 17, 2021 12:06

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 12 November 2021 as the record date ...

Nov 08, 2021 10:38

Nippon India Mutual Fund Announces Appointment of Key Personnel

Nippon India Mutual Fund has announced that Rishit Bipin Parikh has been ap...

Oct 14, 2021 13:37

Nippon India Balanced Advantage Fund Announces Dividend

Nippon India Mutual Fund has announced 12 October 2021 as the record date f...

Oct 07, 2021 12:17

Nippon India Fixed Horizon Fund - XLI - Series 8 change in benchmark

Nippon India Mutual Fund / Nippon Life India Asset Management Limited has d...

Sep 29, 2021 12:36

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Nifty Pharma ETF
Contact Persone : Mehul Dama
Registered Address : Reliance Center, 7th Floor SouthWing, Off Western ExpressHighway, Santacruz(E) Mumbai-400055
Telephone No : 022-43031000/1860 266 0111
Fax No. : 022-43037662
Email : customercare@nipponindiamf.com
Website : www.nipponindiamf.com